Status:
UNKNOWN
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
Tang-Du Hospital
Kunming Medical University
Conditions:
Cerebral Aneurysm
Arteriovenous Malformations
Eligibility:
All Genders
Up to 70 years
Phase:
NA
Brief Summary
In the stage of randomized controlled study, our purpose is to obtain the Intraoperative anticoagulation program supported by evidence-based medicine.
Detailed Description
This study is divided into anticoagulation program in cerebral aneurysm with hybrid operation and anticoagulation program in cerebral arteriovenous malformations with hybrid operation two parts, and e...
Eligibility Criteria
Inclusion
- All patients undergoing hybird surgery.
Exclusion
- Poor general condition , severe primary disease, surgical contraindications
- Patient or family refused surgery
- Fusiform aneurysm,Traumatic aneurysm,Infectious aneurysms
- Combined with other hemorrhagic cerebrovascular disease
- Combined with malignant brain tumor
- Perinatal, Pregnancy
- Patients unwilling to participate in the trial
Key Trial Info
Start Date :
September 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
408 Patients enrolled
Trial Details
Trial ID
NCT03306836
Start Date
September 1 2016
End Date
August 1 2021
Last Update
October 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100050